Heart Failure Science: Top Takeaways from 2022 Part I

Hosts Michael Beasley, MD and Priya Umapathi, MD interview current and immediate past presidents John Teerlink MD, FHFSA, and Mark Drazner MD, MSc, FHFSA on the most significant events that took place in the field of heart failure in 2022 on this two-part series. Part one dives into SGLT2 inhibitors, the rapid uptitration of GDMT, and cardiac xenotransplantation. Michael also delivers HF Rounds, his new segment which features a succinct peek into interesting news from HF journals. Stay tuned for Part II coming in January!